Business Description
Aspira Womens Health Inc
NAICS : 334516
SIC : 3841
ISIN : US04537Y2081
Description
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1 | |||||
| Equity-to-Asset | -0.53 | |||||
| Debt-to-Equity | -0.85 | |||||
| Debt-to-EBITDA | -0.13 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -163.6 | |||||
| Beneish M-Score | -5.65 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.7 | |||||
| 3-Year EBITDA Growth Rate | 8.5 | |||||
| 3-Year EPS without NRI Growth Rate | 9.7 | |||||
| 3-Year FCF Growth Rate | 8.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 48.98 | |||||
| Future 3-5Y Total Revenue Growth Rate | 55.25 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 68.77 | |||||
| 9-Day RSI | 58.06 | |||||
| 14-Day RSI | 53.26 | |||||
| 6-1 Month Momentum % | -37.39 | |||||
| 12-1 Month Momentum % | -81.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.75 | |||||
| Quick Ratio | 0.7 | |||||
| Cash Ratio | 0.39 | |||||
| Days Inventory | 24.89 | |||||
| Days Sales Outstanding | 59.28 | |||||
| Days Payable | 170.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15.1 | |||||
| Shareholder Yield % | 42.08 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 58.12 | |||||
| Operating Margin % | -189.47 | |||||
| Net Margin % | -165.07 | |||||
| FCF Margin % | -162.94 | |||||
| ROA % | -240.12 | |||||
| ROIC % | -1049.7 | |||||
| ROC (Joel Greenblatt) % | -2358.07 | |||||
| ROCE % | -1946.64 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.02 | |||||
| EV-to-EBIT | -0.74 | |||||
| EV-to-EBITDA | -0.74 | |||||
| EV-to-Revenue | 1.38 | |||||
| EV-to-Forward-Revenue | 0.52 | |||||
| EV-to-FCF | -0.85 | |||||
| Price-to-Median-PS-Value | 0.05 | |||||
| Earnings Yield (Greenblatt) % | -135.14 | |||||
| FCF Yield % | -117.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aspira Womens Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 8.219 | ||
| EPS (TTM) (€) | -1.101 | ||
| Beta | 0 | ||
| Volatility % | 58.6 | ||
| 14-Day RSI | 53.26 | ||
| 14-Day ATR (€) | 0.026941 | ||
| 20-Day SMA (€) | 0.69725 | ||
| 12-1 Month Momentum % | -81.47 | ||
| 52-Week Range (€) | 0.64 - 4.02 | ||
| Shares Outstanding (Mil) | 16.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aspira Womens Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aspira Womens Health Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aspira Womens Health Inc Frequently Asked Questions
What is Aspira Womens Health Inc(STU:CUL)'s stock price today?
The current price of STU:CUL is €0.72. The 52 week high of STU:CUL is €4.02 and 52 week low is €0.64.
When is next earnings date of Aspira Womens Health Inc(STU:CUL)?
The next earnings date of Aspira Womens Health Inc(STU:CUL) is 2025-03-28 Est..
Does Aspira Womens Health Inc(STU:CUL) pay dividends? If so, how much?
Aspira Womens Health Inc(STU:CUL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers